+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

M2054 Correlation of Histological Villous Atrophy with Tissue Transglutaminase Antibody Level in Patients with Diagnosis of Celiac Disease: Retrospective Analysis of a Cohort of 187 Celiac Patients



M2054 Correlation of Histological Villous Atrophy with Tissue Transglutaminase Antibody Level in Patients with Diagnosis of Celiac Disease: Retrospective Analysis of a Cohort of 187 Celiac Patients



Gastroenterology 136(5): A-475-A-476




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067061429

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(09)62188-0


Related references

Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies. World Journal of Gastroenterology 12(9): 1430-1434, 2006

High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Digestive and Liver Disease 44(4): 280-285, 2012

Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis. Gastroenterology 153(3): 689-701.E1, 2017

Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 55(1): 44-49, 2012

S2027 Is Villous Atrophy Predictable by High Tissue-Transglutaminases Antibodies (T-Tga) Level in Unselected Adult Patients Evaluated for Celiac Disease (Cd)?. Gastroenterology 138(5): S-304, 2010

Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. American Journal of Clinical Nutrition 67(3): 482-487, 1998

Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. Journal of Clinical Gastroenterology 49(3): 212-217, 2015

Comment to "high tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of coeliac disease". Digestive and Liver Disease 44(10): 885-6; Author Reply 886, 2013

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease. Gastroenterology Research and Practice 2016: 6718590, 2016

Patients of celiac disease with mild villous atrophy are clinically similar to those with moderate to severe atrophy. Indian Journal of Gastroenterology 32(6): 413-414, 2013

Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study. Journal of Gastroenterology 51(11): 1031-1039, 2016

Correlation of Tissue Transglutaminase with Modified Marsh Grading in Celiac Disease: A Prospective Cohort Study. Indian Journal of Pediatrics 84(7): 515-520, 2017

Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. Annals of the New York Academy of Sciences 1109: 212-220, 2007

Presence of tissue transglutaminase IgA antibody as a celiac disease marker in a sample of patients with irritable bowel syndrome. Puerto Rico Health Sciences Journal 34(1): 38-39, 2015

Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease. Nutrients 9(10):, 2017